IP Library Granted Patent US 11,707,465
Granted Patent B2
US 11,707,465 · App. 17/884,346 · Granted Jul 25, 2023

Theacrine-based supplement and method of use thereof in a synergistic combination with caffeine

Inventors: Hector L. Lopez (Cream Ridge, NJ); Shawn Wells (Lewisville, TX); Tim N. Ziegenfuss (Chardon, OH)
Assignee: Ortho-Nutra LLC
A61K31/522A23L33/10A23L33/105A61K31/133A61K31/14A61K31/4748A61K31/685A61K31/7048A61K31/7068C07D487/04A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,707,465
App. No.
17/884,346
Granted
Jul 25, 2023
Kind
B2
Abstract

A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue. A synergistic composition comprises co-administration of theacrine and caffeine, wherein the co-administered caffeine reduces theacrine oral clearance (CL/F) and oral volume of distribution (Vd/F). In addition, the co-administered caffeine increases area under the plasma concentration time curve (AUC) of theacrine, and increases theacrine maximum plasma concentration (C max ) in comparison with the corresponding pharmacokinetic parameters when theacrine is administered alone.

Claims (33)

1. A method of formulating a dietary supplement comprising the step of:

combining a nutraceutically acceptable carrier with theacrine, caffeine, and methylliberine;

wherein the dietary supplement is formulated for oral administration;

wherein the theacrine is present in the dietary supplement in an amount that is to modulate activity of the caffeine; and

wherein the theacrine and caffeine are present in the dietary supplement in a ratio of about 0.5:1 to about 50:1 by weight caffeine:theacrine.

2. The method of claim 1 , wherein the theacrine has a purity of at least 95%.

3. The method of claim 1 , wherein the theacrine is present in the dietary supplement in an amount of from about 5 mg to about 850 mg.

4. The method of claim 1 , wherein the dietary supplement is formulated into a solid oral dosage form.

5. The method of claim 4 , wherein said solid oral dosage form is a powder, capsule, or tablet.

6. The method of claim 1 , wherein the dietary supplement is formulated to, upon oral administration, increase mood, energy, focus, concentration, and/or sexual desire.

7. The method of claim 1 , wherein the theacrine is produced synthetically or is isolated from a natural source and purified to at least 50% theacrine.

8. The method of claim 1 , wherein said caffeine is present in the dietary supplement in an amount of about 25 mg to about 650 mg.

9. The method of claim 1 , wherein the theacrine is present in the dietary supplement in an amount from about 65 mg to about 300 mg.

10. The method of claim 1 , wherein the ratio is about 1:1 to about 10:1.

11. The method of claim 1 , wherein the ratio is about 2:1 to about 4:1.

12. The method of claim 1 , wherein the ratio is about 1.2:1.

13. A method of modulating activity of a stimulant comprising the steps of:

providing a dietary supplement comprising a nutraceutically acceptable carrier in combination with theacrine, caffeine, and methylliberine, and

administering the dietary supplement to a subject to modulate activity of the stimulant;

wherein the dietary supplement is formulated for oral administration;

wherein the stimulant is caffeine, and theacrine is included in the supplement in an amount that modulates activity of the caffeine;

wherein the theacrine and caffeine are present in the dietary supplement in a ratio of about 0.5:1 to about 50:1 by weight caffeine:theacrine.

14. The method of claim 13 , wherein the theacrine has a purity of at least 95%.

15. The method of claim 13 , wherein the theacrine is present in the dietary supplement in an amount of from about 5 mg to about 850 mg.

16. The method of claim 13 , wherein the dietary supplement is formulated into a solid oral dosage form.

17. The method of claim 16 , wherein said solid oral dosage form is a powder, capsule, or tablet.

18. The method of claim 13 , wherein the dietary supplement is formulated to, upon oral administration, increase mood, energy, focus, concentration, and/or sexual desire.

19. The method of claim 13 , wherein the theacrine is produced synthetically or is isolated from a natural source and purified to at least 50% theacrine.

20. The method of claim 13 , wherein said caffeine is present in the dietary supplement in an amount of about 25 mg to about 650 mg.

21. The method of claim 13 , wherein the theacrine is present in the dietary supplement in an amount from about 65 mg to about 300 mg.

22. The method of claim 13 , wherein the ratio is about 1:1 to about 10:1.

23. The method of claim 13 , wherein the ratio is about 2:1 to about 4:1.

24. The method of claim 13 , wherein the ratio is about 1.2:1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2022
From: LOPEZ, HECTOR L.; WELLS, SHAWN; ZIEGENFUSS, TIM N.
To: ORTHO-NUTRA, LLC
Reel/Frame 060761/0952 →
Continuity (5)
Division 16551373 · Aug 26, 2019
Continuation 15600371 · May 19, 2017
Continuation In Part 14539726 · Nov 12, 2014
Provisional Application 61903362 · Nov 12, 2013
Related Publication 20230147386A1 · May 11, 2023